CIK: 0001637359
Total reported value
$163.1M
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | PRTKEUR | Paratek Pharmaceuticals INC | Stock-Other | 32.54% | — | — | |
| 2 | ✓ | Juno Therapeutics | Stock-Other | 17.73% | — | — | |
| 3 | FGENEUR | Fibrogen INC | Stock-Other | 13.02% | — | -1.18% | |
| 4 | EGLTEUR | Egalet CORP | Stock-Other | 9.58% | — | — | |
| 5 | ✓ | Nabriva Therapeutics AG | Stock-Other | 8.94% | — | — | |
| 6 | JNCEEUR | Jounce Therapeutics INC | Stock-Other | 8.29% | — | — | |
| 7 | ✓ | Essa Pharma INC | Stock-Other | 3.44% | — | — | |
| 8 | PIRSEUR | Pieris Pharmaceuticals INC | Stock-Other | 2.87% | — | — | |
| 9 | ✓ | Cidara Therapeutics INC Com New | Stock-Other | 2.26% | — | -10.12% | |
| 10 | CBAYUSD | Cymabay Therapeutics INC | Stock-Other | 0.84% | — | — | |
| 11 | DRNAUSD | Dicerna Pharmaceuticals INC | Stock-Other | 0.49% | — | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | ✓ | Nabriva Therapeutics AG | +3.4% | — | Unchanged |
| 2 | PIRSEUR | Pieris Pharmaceuticals INC | +0.9% | — | Unchanged |
| 3 | ✓ | Essa Pharma INC | +0.4% | — | Unchanged |
| 4 | CBAYUSD | Cymabay Therapeutics INC | +0.4% | — | Unchanged |
| 5 | PRTKEUR | Paratek Pharmaceuticals INC | 0% | — | Unchanged |
| 6 | DRNAUSD | Dicerna Pharmaceuticals INC | 0% | — | Unchanged |
| 7 | ✓ | Juno Therapeutics | -1.1% | — | Unchanged |
| 8 | FGENEUR | Fibrogen INC | -1.3% | -1.18% | Trim |
| 9 | ✓ | Cidara Therapeutics INC Com New | -1.9% | -10.12% | Trim |
| 10 | EGLTEUR | Egalet CORP | -8.4% | — | Unchanged |
| 11 | JNCEEUR | Jounce Therapeutics INC | — | NEW | New buy |
| 12 | EDIT | Editas Medicine INC | — | EXIT | Sold out |
| 13 | PRTOEUR | Proteon Therapeutics INC | — | — | Unchanged |